CN1566097A - 5-〔对-(2-吡啶胺磺酰基)苯〕偶氮水杨酸纯化工艺 - Google Patents
5-〔对-(2-吡啶胺磺酰基)苯〕偶氮水杨酸纯化工艺 Download PDFInfo
- Publication number
- CN1566097A CN1566097A CN 03129670 CN03129670A CN1566097A CN 1566097 A CN1566097 A CN 1566097A CN 03129670 CN03129670 CN 03129670 CN 03129670 A CN03129670 A CN 03129670A CN 1566097 A CN1566097 A CN 1566097A
- Authority
- CN
- China
- Prior art keywords
- acid
- sasp
- pyridine
- finished product
- dmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000000746 purification Methods 0.000 title abstract description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 title abstract description 3
- -1 azo salicylic acid Chemical compound 0.000 title abstract description 3
- 229960004889 salicylic acid Drugs 0.000 title abstract description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 title abstract 2
- NCEXYHBECQHGNR-UHFFFAOYSA-N chembl421 Chemical compound C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000047 product Substances 0.000 claims abstract description 22
- 102100033717 Retroviral-like aspartic protease 1 Human genes 0.000 claims abstract description 21
- 101710188689 Small, acid-soluble spore protein 1 Proteins 0.000 claims abstract description 21
- 101710188693 Small, acid-soluble spore protein 2 Proteins 0.000 claims abstract description 21
- 101710166422 Small, acid-soluble spore protein A Proteins 0.000 claims abstract description 21
- 101710166404 Small, acid-soluble spore protein C Proteins 0.000 claims abstract description 21
- 101710174019 Small, acid-soluble spore protein C1 Proteins 0.000 claims abstract description 21
- 101710174017 Small, acid-soluble spore protein C2 Proteins 0.000 claims abstract description 21
- 101710174574 Small, acid-soluble spore protein gamma-type Proteins 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 13
- 238000000926 separation method Methods 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- 239000012043 crude product Substances 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 239000003513 alkali Substances 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- QQBDLJCYGRGAKP-FOCLMDBBSA-N olsalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=C(C(O)=CC=2)C(O)=O)=C1 QQBDLJCYGRGAKP-FOCLMDBBSA-N 0.000 claims description 4
- 229960004110 olsalazine Drugs 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 101710166563 Small, acid-soluble spore protein I Proteins 0.000 description 8
- 239000012065 filter cake Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 238000009413 insulation Methods 0.000 description 8
- 238000007670 refining Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000005554 pickling Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- XNLWJFYYOIRPIO-UHFFFAOYSA-N 3-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1 XNLWJFYYOIRPIO-UHFFFAOYSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- WILKPBCVHVMTJO-UHFFFAOYSA-N OC1=C(C=C(C=C1)N=NC1=CC=C(C=C1)N1C(C=CC=C1)N)C(=O)O Chemical compound OC1=C(C=C(C=C1)N=NC1=CC=C(C=C1)N1C(C=CC=C1)N)C(=O)O WILKPBCVHVMTJO-UHFFFAOYSA-N 0.000 description 1
- SIWLKFXKWUUXNH-UHFFFAOYSA-N OC1=C(C=C(C=C1)N=NS(=O)(=O)C1=CC=CC=C1)C(=O)O Chemical compound OC1=C(C=C(C=C1)N=NS(=O)(=O)C1=CC=CC=C1)C(=O)O SIWLKFXKWUUXNH-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 description 1
- 229960002211 sulfapyridine Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03129670 CN1261413C (zh) | 2003-07-01 | 2003-07-01 | 柳氮磺吡啶纯化工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03129670 CN1261413C (zh) | 2003-07-01 | 2003-07-01 | 柳氮磺吡啶纯化工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1566097A true CN1566097A (zh) | 2005-01-19 |
CN1261413C CN1261413C (zh) | 2006-06-28 |
Family
ID=34469402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03129670 Expired - Lifetime CN1261413C (zh) | 2003-07-01 | 2003-07-01 | 柳氮磺吡啶纯化工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1261413C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103044323A (zh) * | 2012-12-27 | 2013-04-17 | 浙江九洲药业股份有限公司 | 一种柳氮磺吡啶的纯化方法 |
CN103709098A (zh) * | 2013-12-27 | 2014-04-09 | 浙江九洲药业股份有限公司 | 柳氮磺吡啶晶型及其制备方法 |
CN104130186A (zh) * | 2014-06-30 | 2014-11-05 | 江苏瑞克医药科技有限公司 | 一种提高柳氮磺吡啶精制生产效率的方法 |
CN105330599A (zh) * | 2015-11-26 | 2016-02-17 | 苏州统华药品有限公司 | 一种以2-氨基吡啶为原料合成柳氮磺吡啶的方法 |
CN105348184A (zh) * | 2015-11-26 | 2016-02-24 | 苏州统华药品有限公司 | 一种柳氮磺吡啶的制备方法 |
CN105367488A (zh) * | 2015-11-26 | 2016-03-02 | 苏州统华药品有限公司 | 一种柳氮磺吡啶的纯化方法 |
CN105367489A (zh) * | 2015-11-26 | 2016-03-02 | 苏州统华药品有限公司 | 一种以磺胺吡啶为原料合成柳氮磺吡啶的方法 |
CN106032357A (zh) * | 2015-03-11 | 2016-10-19 | 浙江九洲药物科技有限公司 | 柳氮磺吡啶杂质及其制备方法 |
CN106279008A (zh) * | 2015-05-19 | 2017-01-04 | 浙江九洲药业股份有限公司 | 一种柳氮磺吡啶的纯化工艺 |
CN108264481A (zh) * | 2017-01-03 | 2018-07-10 | 江苏瑞科医药科技有限公司 | 柳氮磺吡啶晶型及其制备方法 |
-
2003
- 2003-07-01 CN CN 03129670 patent/CN1261413C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103044323A (zh) * | 2012-12-27 | 2013-04-17 | 浙江九洲药业股份有限公司 | 一种柳氮磺吡啶的纯化方法 |
CN103044323B (zh) * | 2012-12-27 | 2017-12-19 | 浙江九洲药业股份有限公司 | 一种柳氮磺吡啶的纯化方法 |
CN103709098A (zh) * | 2013-12-27 | 2014-04-09 | 浙江九洲药业股份有限公司 | 柳氮磺吡啶晶型及其制备方法 |
CN104130186A (zh) * | 2014-06-30 | 2014-11-05 | 江苏瑞克医药科技有限公司 | 一种提高柳氮磺吡啶精制生产效率的方法 |
CN106032357A (zh) * | 2015-03-11 | 2016-10-19 | 浙江九洲药物科技有限公司 | 柳氮磺吡啶杂质及其制备方法 |
CN106279008A (zh) * | 2015-05-19 | 2017-01-04 | 浙江九洲药业股份有限公司 | 一种柳氮磺吡啶的纯化工艺 |
CN105330599A (zh) * | 2015-11-26 | 2016-02-17 | 苏州统华药品有限公司 | 一种以2-氨基吡啶为原料合成柳氮磺吡啶的方法 |
CN105348184A (zh) * | 2015-11-26 | 2016-02-24 | 苏州统华药品有限公司 | 一种柳氮磺吡啶的制备方法 |
CN105367488A (zh) * | 2015-11-26 | 2016-03-02 | 苏州统华药品有限公司 | 一种柳氮磺吡啶的纯化方法 |
CN105367489A (zh) * | 2015-11-26 | 2016-03-02 | 苏州统华药品有限公司 | 一种以磺胺吡啶为原料合成柳氮磺吡啶的方法 |
CN105348184B (zh) * | 2015-11-26 | 2020-12-29 | 苏州统华药品有限公司 | 一种柳氮磺吡啶的制备方法 |
CN108264481A (zh) * | 2017-01-03 | 2018-07-10 | 江苏瑞科医药科技有限公司 | 柳氮磺吡啶晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1261413C (zh) | 2006-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1261413C (zh) | 柳氮磺吡啶纯化工艺 | |
CN101486716B (zh) | 利福平的制备方法 | |
CN105820126B (zh) | 一种奥拉帕尼的制备方法 | |
CN107522631B (zh) | 一种盐酸土霉素的制备方法 | |
CN102766185B (zh) | 一种从熊去氧胆酸废母液中分别回收熊去氧胆酸和鹅去氧胆酸的方法 | |
CN106478725A (zh) | 高纯度膦丙替诺福韦中间体的制备方法及其应用 | |
CN101434566A (zh) | 对甲砜基甲苯的生产工艺 | |
CN112457266A (zh) | 一种缬沙坦母液回收方法 | |
CN1137998C (zh) | 酶解法生产肝素钠 | |
CN1687074A (zh) | 左氧氟沙星制备的后处理方法 | |
WO2009086728A1 (zh) | 一种制备瑞格列奈的方法 | |
CN101928214B (zh) | 右旋酮洛芬氨丁三醇的一种合成方法 | |
CN103980249A (zh) | 一种苯甲酸阿格列汀的精制方法 | |
CN103113294A (zh) | 瑞巴派特的合成方法 | |
CN1293041C (zh) | D-(-)-1-苯甘氨酸的制备方法 | |
CN1803773A (zh) | 氟尼辛葡甲胺的合成提取精制方法 | |
CN105541951A (zh) | 一种奥贝胆酸的精制方法 | |
CN101910112B (zh) | S-3-氨甲基-5-甲基己酸拆分工艺 | |
CN1526700A (zh) | 枸橼酸莫沙必利重要中间体的合成工艺 | |
CN108586272A (zh) | 一种3-氨基丙醇或3-氨基丙酸衍生物的制备方法 | |
CN1226278C (zh) | 盐酸去甲金霉素结晶母液的回收方法 | |
CN1793138A (zh) | 一种酮色林的制备方法 | |
CN1199961C (zh) | Dl-泛酰内酯的拆分方法 | |
CN1740138A (zh) | 从苯酐硝化制备3-硝基邻苯二甲酸的反应母液中制备4-硝基邻苯二甲酸的方法 | |
CN1944409A (zh) | 一种制备具有高光学纯度精吡氟氯禾灵的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANGHAI SUNVE PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 200331 No. 50, Yongdeng Road, Shanghai, China Patentee after: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL Co.,Ltd. Address before: 200331 No. 50, Yongdeng Road, Shanghai, Putuo District Patentee before: Shanghai Sunve Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20060628 |
|
CX01 | Expiry of patent term | ||
DD01 | Delivery of document by public notice |
Addressee: Pan Haifei Document name: Notice of Termination of Patent Rights |
|
DD01 | Delivery of document by public notice |